Page 73 - Quest Diagnostics News Today

Convenient as it may be, beware of getting your blood drawn at a hospital. The cost could be much higher than at an independent lab, and your insurance might not cover it all.

Reesha Ahmed was on cloud nine. It was January and Ahmed was at an OB-GYN's office near her home in Venus, Texas, for her first prenatal checkup.

Convenient as it may be, beware of getting your blood drawn at a hospital. The cost could be much higher than at an independent lab, and your insurance might not cover it all.

Health systems in Oregon, Massachusetts, Pennsylvania and New York are selling off their lab businesses due to financial difficulties. 5 health systems have bee

Unlock the buzz surrounding Quest’s Alzheimer’s Blood Test: Is it a bold leap forward or a costly gamble?

StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a report issued on Wednesday morning. Several other research firms have also issued reports on DGX. TheStreet lowered shares of Quest Diagnostics from a b- rating to a c rating in a research report on Tuesday, […]

Bank of Hawaii lessened its stake in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 2.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,318 shares of the medical research company’s stock after selling 163 shares during the […]

The CDC report states that allergic diseases such as asthma are a growing concern in the U.S. cannabis industry.

Oncology Precision Medicine Market Analysis and Future Prospects for 2030

Bank of Hawaii trimmed its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 2.5% in the 2nd quarter, HoldingsChannel reports. The firm owned 6,318 shares of the medical research company’s stock after selling 163 shares during the quarter. Bank of Hawaii’s holdings in Quest Diagnostics were worth $888,000 at the end of the […]